The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Gatineau Hospital: Towards a community transformation Apr 13, 2021
- Fear of bottle gatherings now that restrictions have ended Sep 7, 2021
- Before Pfizer and Moderna, Variante Lambda does not neutralize vaccines Aug 29, 2021
- Not only light, but these dangerous symptoms of coronavirus Jul 14, 2020
- One and a half million Lombards have not even booked the first dose of the vaccine Aug 10, 2021
- Events Etla explained: The coronavirus devastated the scene Sep 6, 2021
- These are 9 foods that help you sleep better | Video May 31, 2021